Pitavastatin Calcium/Ezetimibe | Interleukin Related interleukin-related.com

Product Name :
Pitavastatin Calcium/Ezetimibe

Search keywords :
Ezetimibe

drugId :
null

Target Vo:
HMG-CoA reductase

Target Vo Short Name :
HMGCR

Moa_Name:
HMG-CoA reductase inhibitors

First Approval Country :
Japan

First Approval Date Filter:
2022

Origin Company_Name :
Orient Pharma Co Ltd

Active Company_Name :
Kowa Co Ltd

Active Indication_Name:
Hypercholesterolemia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD68 (YP5054) Mouse mAb Autophagy
Atoltivimab Filovirus
BRG1 Antibody (YA817): BRG1 Antibody (YA817) is a non-conjugated and Mouse origined monoclonal antibody about 185 kDa, targeting to BRG1 (6D7). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts